Cohlhepp Ryan — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Cohlhepp Ryan has filed 3 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $3.45M.

Profile

Ryan Cohlhepp is the President and COO of Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company focused on developing bifunctional therapies for solid tumors. He has also served as a Director at the company, contributing to its strategic direction and operations.

Board memberships

• Bicara Therapeutics Inc.

Awards & honors

• Leadership in clinical-stage biopharmaceutical development
• Oversight of transformative therapy programs

Recent Transactions

Companies — Last 90 Days

• Bicara Therapeutics Inc. (BCAX) — 3 filings, last 2026-07-10

Frequently Asked Questions

Who is Cohlhepp Ryan?

Ryan Cohlhepp is the President and COO of Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company focused on developing bifunctional therapies for solid tumors. He has also served as a Director at the company, contributing to its strategic direction and operations.…

How many SEC Form 4 filings has Cohlhepp Ryan submitted recently?

3 primary Form 4 filings in the last 90 days, covering 1 company.

Has Cohlhepp Ryan been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 24 open-market sales ($3.45M) across all tracked filings.

Where can I see all of Cohlhepp Ryan's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week